# Assessing the Vaccination Status and Barriers to Influenza, Pneumococcal, and COVID-19 Vaccination Among Moroccan Patients With Chronic Inflammatory Rheumatic Disease

**Authors:** Samya Ez-zaoui, Hanan Rkain, Fatine Kronbi, Nada Benzine, Sara Farih, Latifa Tahiri, Redouane Abouqal, Kenza Hassouni, Najia Hajjaj-Hassouni, Fadoua Allali

PMC · DOI: 10.7759/cureus.61676 · Cureus · 2024-06-04

## TL;DR

This study finds that Moroccan patients with chronic rheumatic diseases are under-vaccinated against influenza and pneumococcus, and hesitant about the COVID-19 vaccine due to lack of doctor recommendations and fear of side effects.

## Contribution

The study provides insights into vaccination coverage and hesitancy factors specific to Moroccan patients with chronic inflammatory rheumatic diseases.

## Key findings

- Only 2.2% of patients were vaccinated against influenza and 0.4% against pneumococcus.
- Fear of vaccine side effects, especially flare-ups of rheumatic disease, was the main reason for avoiding the COVID-19 vaccine.
- Lack of doctor recommendations was the primary cause for not getting influenza and pneumococcal vaccines.

## Abstract

Objective: To evaluate the vaccination coverage of patients with chronic inflammatory rheumatic disease (CIRD) against influenza, pneumococcus, and COVID-19 and to determine, per the patients' point of view, the possible factors related to vaccination hesitation and/or refusal.

Methods: A cross-sectional study carried out by the vaccination working group of the Moroccan Society of Rheumatology, including patients with CIRD in Morocco. Information about vaccination coverage and reasons for non-vaccination against influenza, pneumococcal infection, and COVID-19 was collected.

Results: This survey included 230 patients (mean age of 46.9 +/-13.89 years; 68.7% females) affected by CIRD (rheumatoid arthritis 53%, spondyloarthritis 39.6%, psoriatic arthritis 7%). The study shows a significant lack of influenza and pneumococcal vaccination in CIRD patients, with vaccination coverage against influenza, pneumococcal infection, and COVID-19 at 2.2%, 0.4%, and 80.9%, respectively. The main reason for non-vaccination against influenza and pneumococcus was related to the absence of recommendations by their doctors (77%, 87%, p = 0.04). Additionally, the primary reason for non-vaccination against COVID-19 was the fear of the vaccine's side effects (51%, p = 0.0001), mainly a flare-up of CIRD (44%, p = 0.001).

Conclusion: This survey shows a lack of influenza, pneumococcal, and COVID-19 vaccination in CIRD patients. The principal actions to improve vaccination should aim to educate patients and encourage rheumatologists to vaccinate their patients.

## Linked entities

- **Diseases:** rheumatoid arthritis (MONDO:0008383), spondyloarthritis (MONDO:0005095), psoriatic arthritis (MONDO:0011849)

## Full-text entities

- **Diseases:** spondyloarthritis (MESH:D013167), CIRD (MESH:D012213), Pneumococcal (MESH:D011008), COVID-19 (MESH:D000086382), rheumatoid arthritis (MESH:D001172), Influenza (MESH:D007251), psoriatic arthritis (MESH:D015535)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11149921/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11149921/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC11149921/full.md

---
Source: https://tomesphere.com/paper/PMC11149921